304.51

+0.24%↑

CAT

552.7

-0.23%↓

RTX

175.42

+0.89%↑

GEV.US

577.2

+3.61%↑

194.44

-0.06%↓

304.51

+0.24%↑

CAT

552.7

-0.23%↓

RTX

175.42

+0.89%↑

GEV.US

577.2

+3.61%↑

194.44

-0.06%↓

304.51

+0.24%↑

CAT

552.7

-0.23%↓

RTX

175.42

+0.89%↑

GEV.US

577.2

+3.61%↑

194.44

-0.06%↓

304.51

+0.24%↑

CAT

552.7

-0.23%↓

RTX

175.42

+0.89%↑

GEV.US

577.2

+3.61%↑

194.44

-0.06%↓

304.51

+0.24%↑

CAT

552.7

-0.23%↓

RTX

175.42

+0.89%↑

GEV.US

577.2

+3.61%↑

194.44

-0.06%↓

Home・Aandelen Lijst・India Globalization Capital Inc

India Globalization Capital Inc

Gesloten

0.35 -2.78

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.35

Max

0.35

Belangrijke statistieken
By Trading Economics
Inkomsten	-402K -1.6M
Verkoop	-2K 328K
Winstmarge	-487.5
Werknemers	70
EBITDA	-506K -1.8M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+1150% upside

Dividenden
By Dow Jones
Volgende Winsten	11 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	6.3M 35M
Vorige openingsprijs	3.13
Vorige sluitingsprijs	0.35

India Globalization Capital Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 nov 2025, 17:45 UTC

Winsten

Belangrijke Marktbewegers

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

14 nov 2025, 17:31 UTC

Winsten

Belangrijke Marktbewegers

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

14 nov 2025, 16:15 UTC

Belangrijke Marktbewegers

Scholar Rock Shares Rise on Renewed Apitegromab Hopes

14 nov 2025, 23:56 UTC

Acquisities, Fusies, Overnames

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

14 nov 2025, 23:02 UTC

Marktinformatie

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

14 nov 2025, 22:35 UTC

Winsten

Acquisities, Fusies, Overnames

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

14 nov 2025, 22:32 UTC

Acquisities, Fusies, Overnames

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

14 nov 2025, 22:29 UTC

Winsten

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

14 nov 2025, 22:00 UTC

Acquisities, Fusies, Overnames

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

14 nov 2025, 21:50 UTC

Marktinformatie

Winsten

Tech, Media & Telecom Roundup: Market Talk

14 nov 2025, 21:18 UTC

Acquisities, Fusies, Overnames

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

14 nov 2025, 20:27 UTC

Marktinformatie

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

14 nov 2025, 20:23 UTC

Marktinformatie

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

14 nov 2025, 20:17 UTC

Acquisities, Fusies, Overnames

Several State Attorneys General Oppose Railroad Merger -- WSJ

14 nov 2025, 19:29 UTC

Marktinformatie

Winsten

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

14 nov 2025, 18:44 UTC

Marktinformatie

Winsten

Disney's Growth Now Hinges More on ESPN -- Market Talk

14 nov 2025, 18:27 UTC

Marktinformatie

Global Equities Roundup: Market Talk

14 nov 2025, 18:27 UTC

Marktinformatie

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

14 nov 2025, 18:20 UTC

Marktinformatie

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

14 nov 2025, 17:20 UTC

Marktinformatie

Winsten

Auto & Transport Roundup: Market Talk

14 nov 2025, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

14 nov 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

14 nov 2025, 16:51 UTC

Marktinformatie

Starbucks Gets Holiday Sales Lift -- Market Talk

14 nov 2025, 16:48 UTC

Marktinformatie

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

14 nov 2025, 16:38 UTC

Marktinformatie

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

14 nov 2025, 16:30 UTC

Acquisities, Fusies, Overnames

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

14 nov 2025, 16:28 UTC

Marktinformatie

Ukraine Strike on Russian Port Lifts Distillates -- Market Talk

14 nov 2025, 15:59 UTC

Marktinformatie

U.S. Natural Gas Inventories Rise More Than Expected -- Market Talk

14 nov 2025, 15:06 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

14 nov 2025, 15:06 UTC

Marktinformatie

Dollar Could Benefit From U.K., French Fiscal Concerns -- Market Talk

Peer Vergelijking

Prijswijziging

India Globalization Capital Inc Prognose

Koersdoel

By TipRanks

1150% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 4.5 USD 1150%

Hoogste 4.5 USD

Laagste 4.5 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor India Globalization Capital Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan India Globalization Capital Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over India Globalization Capital Inc

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.